Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.

Gilio, Francesca

Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study. [electronic resource] - Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases Aug 2010 - 359-63 p. digital

Publication Type: Journal Article

1471-180X

10.3109/17482960903264998 doi


Aged
Aged, 80 and over
Amyotrophic Lateral Sclerosis--complications
Botulinum Toxins, Type A--pharmacology
Case-Control Studies
Dose-Response Relationship, Drug
Electric Stimulation--methods
Electromyography--methods
Evoked Potentials, Motor--drug effects
Female
Humans
Male
Middle Aged
Muscle, Skeletal--physiopathology
Neuromuscular Agents--pharmacology
Pain Measurement
Parotid Gland--drug effects
Prospective Studies
Sialorrhea--drug therapy